<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="622">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>1/11/2005</approvaldate>
  <actrnumber>ACTRN12605000700639</actrnumber>
  <trial_identification>
    <studytitle>Oesophageal Trial</studytitle>
    <scientifictitle>A Randomised Phase III Clinical Trial
Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Australasian Gastro-Intestinal Trials Group: IG9401</secondaryid>
    <secondaryid>National Clinical Trials Registry: NCTR117</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Oesophageal carcinoma</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Oesophageal (gullet)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>6 months of preoperative chemotherapy and radiotherapy followed by surgery vs surgery alone</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Progression free survival</outcome>
      <timepoint />
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Overall survival</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Toxicity</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Histologically proven invasive squamous cell carcinoma or adenocarcinoma of the oesophagus.Technically resectable disease, as assessed in consultation with intended surgeon, with no planned post-operative anti-tumour treatment.No evidence of extrathoracic spread. (Tumour in supraclavicular and/or coeliac nodes renders patient ineligible.)Tumour is NOT located in cervical oesophagus requiring pharyngo-oesophagectomy.Tumour is NOT predominantly below the oesophagogastric junction and involving the stomach. (i.e. Most of the macroscopically visible tumour must be above the O-G junction and technically within the oesophagus.)Medically fit for surgical resection, defined as having adequate cardiopulmonary function and ECOG performance status of 0 or 1.Adequate haematological function, defined as having WBC &gt; 4 x 109/litre and platelets &gt; 100 x 109/litre.Adequate renal function, defined as creatinine clearance &gt; 60 ml/min calculated (using Cockcroft &amp; Gault formula - see Appendix 6). If calculated creatinine clearance is &lt; 60ml/min, glomerular filtration rate can be measured by an alternative method. If results from this are creatinine clearance &gt; 60mls/min the patient is eligible.No previous radiotherapy to the chest, no previous chemotherapy.No previous malignancy, with the exception of non-metastatic SCC of skin, other non-melanoma skin cancer, carcinoma in situ of the cervix. Cases for Special Eligibility with regard to this criteria may be presented to the study chair for discussion.No evidence of tracheo- or broncho-oesophageal fistula.Not pregnant or lactating.Written informed consent of the patient according to local ethics committee guidelines.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>centralised randomisation database</concealment>
    <sequence>computer software</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/11/1994</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>250</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>AGITG/NHMRC Clinical Trials Centre</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Grants</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other Collaborative groups</sponsortype>
      <sponsorname>AGITG</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Bryan Burmeister</name>
      <address>Queensland Radium Institute
Mater Centre
South Brisbane QLD 4101</address>
      <phone>+61 7 38403255</phone>
      <fax>+61 7 38403399</fax>
      <email>bryan_burmeister@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Burcu Cakir</name>
      <address>Locked Bag 77
Camperdown NSW 1450</address>
      <phone>+61 2 95625334</phone>
      <fax>+61 2 95625094</fax>
      <email>bcakir@ctc.usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>